Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-23-047180

Chief Executive Officer gave up 692 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Collard Craig A Chief Executive Officer 2023-08-22 Shares withheld for taxes −692 $1.65 $1,142 36,496 D
Loading xslF345X05/doc4.xml…